Xeraya Capital β Full Portfolio
10 tracked investments Β· listed companies and verified rows first
P2 Science develops green chemistry platform technologies (including its PIOz ozonolysis and PICE polymerization processes) that convert renewable, plant-based oils into functional intermediates, specialty ingredients, and polymers.
BiotechCircular EconomyCleantechNew MaterialsWoodbridge, US
Paul Anastas(Co-founder)Patrick Foley(Co-founder & President)inNeil A. Burns(Executive Officer, Director)Oihana Elizalde(Chief Executive Officer)inBrian Chan(Chief Financial Officer)inKevin Gallagher(Director)
Co-investorsCircular Innovation FundConnecticut InnovationsEmerald Technology Ventures AgHG VenturesSafer MadeCycle Capital+1 more
All G produces high-value proteins using precision fermentation technology for infant formula, dietary supplements, and personal care applications.
AgTechBiotechDeep TechFoodTechSydney, AU
Jan Pacas(CEO)inJared Raynes(Chief Scientific Officer)in
.jpg)
Co-investorsAgronomicsVirescent VenturesEllerston Capital
BiotechHealthtechSt. Paul, US
Joshua Woolley(Executive Officer)inRyan Gladney(Executive Officer)Gary Graham(Executive Officer)Dan W. Gladney(Executive Officer, Director)inPeter DeLange(Executive Officer)inBruce A. Machmeier(Executive Officer)
Co-investorsAngel Physicians FundBrightstone Venture CapitalBroadview VenturesPortfoliaCatalyst Health Ventures
Consumer Physics (SCiO) makes a handheld near-infrared spectroscopy scanner paired with a database of molecular signatures to analyze the chemical composition of physical materials.
AgTechAI & Machine LearningDeep TechFoodTechHardwareHerzliya
Damian Goldring(Executive Officer)inDror Sharon(Executive Officer, Director)inHaiyin Shen(Director)William Rosenzweig(Director)
BoardBenny Buller(Director)
Co-investorsSpruce Capital PartnersKhosla VenturesOurCrowd
A pharmaceutical company that develops medicines and vaccines, with research pipelines and clinical trials aimed at new treatments.
BiotechHealthtech
Co-investorsHighlight CapitalAmgen VenturesBlackRockBlackstone Life SciencesClarus VenturesFrazier Healthcare Partners+4 more
BiotechPhoenix, US
Douglas Grant McFadden, Ph.D.(Director)Steven J. Potts, Ph.D.(President and Chief Executive Officer)Ting Xiao(Director)Jason Rushton(Director)Kanad Das, Ph.D.(Director)Michael G. Wood(Executive Officer)
Co-investorsB Capital GroupBoehringer Ingelheim Venture FundCity Hill VenturesDelos CapitalKorea Investment PartnersLumira Ventures+1 more
.jpeg){kind=logo}
AgTechSanta Monica, US
Frances Arnold(Director)inPeter Meinhold(Executive Officer)inPedro Coelho(Executive Officer)inCorey Huck(Executive Officer, Director)in
BoardGANESH KISHORE(Director)inALAN BOYCE(Director)
Co-investorsAliment CapitalKairos Venture Investments, LlcPontifax AgTechSpruce Capital PartnersVivo CapitalKairos Venture Partners
Spruce Capital Partners creates, advises, and invests in life sciences companies that make positive environmental impacts and improve human health and wellness.
BiotechClimate TechHealthtech
Roger WyseGanesh KishoreGreg Young
Other
Tracked investments with no reachable website or further public details β typically companies that wound down, renamed, or were absorbed.
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.